Inventor · Zhejiang, CN

Lieming DING

14Patents
1h-index
38Co-inventors
50Inventor score

Filing activity: Jul 7, 2009 → Aug 29, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8951959B2 Glucagon-like peptide-1 analogues and uses thereof Human Necessities 6 Active
US8822482B2 Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof Chemistry; Metallurgy 1 Active
US11053238B2 Benzimidazole derivatives, preparation methods and uses thereof Chemistry; Metallurgy 1 Active
US11365196B2 FGFR inhibitor and application thereof Chemistry; Metallurgy 1 Active
US11466034B2 Compound functioning as bromodomain protein inhibitor, and composition Chemistry; Metallurgy 0 Active
US9505774B2 Polymorphic forms of icotinib maleate and uses thereof Chemistry; Metallurgy 0 Active
US12043622B2 Crystal form of compound for inhibiting the activity of CDK4/6 and use thereof Chemistry; Metallurgy 0 Active
US11466013B2 ERK inhibitor and use thereof Chemistry; Metallurgy 0 Active
US11845762B2 Compound functioning as bromodomain protein inhibitor, and composition Chemistry; Metallurgy 0 Active
US9611272B2 Polymorphic forms of icotinib and uses thereof Human Necessities 0 Active
US12187713B2 Immunomodulators, compositions and methods thereof Chemistry; Metallurgy 0 Active
US9688687B2 Polymorphic forms of icotinib phosphate and uses thereof Chemistry; Metallurgy 0 Active
US9359370B2 Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof Chemistry; Metallurgy 0 Active
US9487570B2 Glucagon like peptide analogs, composition, and method of use Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.